sb 203580 has been researched along with Ataxia Telangiectasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brook, AJ; Davis, T; Kipling, D; Rokicki, MJ; Tivey, HS | 1 |
| Kim, J; Wong, PK | 1 |
2 other study(ies) available for sb 203580 and Ataxia Telangiectasia
| Article | Year |
|---|---|
p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes.
Topics: Ataxia Telangiectasia; Cells, Cultured; Cellular Senescence; Fibroblasts; Genomic Instability; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Progeria; Protein Kinase Inhibitors; Pyridines; Stress, Physiological; Syndrome; Telomerase; Werner Syndrome | 2013 |
Targeting p38 mitogen-activated protein kinase signaling restores subventricular zone neural stem cells and corrects neuromotor deficits in Atm knockout mouse.
Topics: Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; MAP Kinase Signaling System; Mice; Mice, Knockout; Neural Stem Cells; Neuromuscular Diseases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Purkinje Cells; Pyridines; Tumor Suppressor Proteins | 2012 |